Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer

Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer

Anqi Lin,1,&ast; Jiarong Yao,1,&ast; Quan Cheng,2,3 Zaoqu Liu,4 Peng Luo,1 Jian Zhang1 1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha,...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Lin A, Yao J, Cheng Q, Liu Z, Luo P, Zhang J
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	Dove Medical Press 2023-04-01
Cyfres:	Journal of Inflammation Research
Pynciau:	notch crc icis biomarker tumour microenvironment
Mynediad Ar-lein:	https://www.dovepress.com/mutations-status-of-notch-signaling-pathway-predict-prognosis-of-immun-peer-reviewed-fulltext-article-JIR

Eitemau Tebyg

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors
gan: Yipeng Song, et al.
Cyhoeddwyd: (2021-02-01)

TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
gan: Anqi Lin, et al.
Cyhoeddwyd: (2021-09-01)

Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
gan: Sheng-Kai Hsu, et al.
Cyhoeddwyd: (2022-10-01)

Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer
gan: Xianchao Sun, et al.
Cyhoeddwyd: (2022-06-01)

The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC
gan: Xiaohua Li, et al.
Cyhoeddwyd: (2021-07-01)

Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments
gan: Dong-Xu Wang, et al.
Cyhoeddwyd: (2024-01-01)

NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
gan: Huang Q, et al.
Cyhoeddwyd: (2023-12-01)

Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours
gan: Meghali Goswami, et al.
Cyhoeddwyd: (2024-08-01)

Cholesterol: The driving force behind the remodeling of tumor microenvironment in colorectal cancer
gan: Ke Wang, et al.
Cyhoeddwyd: (2024-12-01)

Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer
gan: Jesper Bertram Bramsen, et al.
Cyhoeddwyd: (2017-05-01)

Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
gan: Said SS, et al.
Cyhoeddwyd: (2025-01-01)

The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
gan: Brigida Anna Maiorano, et al.
Cyhoeddwyd: (2022-10-01)

Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma
gan: John Wen‐Cheng Chang, et al.
Cyhoeddwyd: (2023-01-01)

The role of Hedgehog and Notch signaling pathway in cancer
gan: Ruolan Xia, et al.
Cyhoeddwyd: (2022-12-01)

B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
gan: Lin A, et al.
Cyhoeddwyd: (2022-09-01)

mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers
gan: Lei Cheng, et al.
Cyhoeddwyd: (2022-05-01)

Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer
gan: Stefan A. Cieslik, et al.
Cyhoeddwyd: (2025-01-01)

A real‐world study of immune checkpoint inhibitors in advanced triple‐negative breast cancer
gan: Zheng Zhang, et al.
Cyhoeddwyd: (2023-06-01)

miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization
gan: Xiaobin Lin, et al.
Cyhoeddwyd: (2019-02-01)

Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma
gan: Anqi Lin, et al.
Cyhoeddwyd: (2021-10-01)

Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment
gan: Kai Huang, et al.
Cyhoeddwyd: (2023-01-01)

Association of Tumour Budding With Histological Type And Grade, Pathological Stage And Lymph Node Metastasis In Colorectal Carcinoma
gan: Wajahat Ahmed Khan, et al.
Cyhoeddwyd: (2024-02-01)

Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer
gan: Yi Ding, et al.
Cyhoeddwyd: (2022-09-01)

Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
gan: Somayeh Vafaei, et al.
Cyhoeddwyd: (2022-01-01)

SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer
gan: Yiming Ma, et al.
Cyhoeddwyd: (2022-11-01)

Tumor circulating biomarkers in colorectal cancer
gan: Raana Bagheri, et al.
Cyhoeddwyd: (2024-01-01)

Constructing a signature based on the SIRT family to help the prognosis and treatment sensitivity in glioma patients
gan: Feiyue Xuan, et al.
Cyhoeddwyd: (2022-12-01)

Correlation between mismatch repair statuses and the prognosis of stage I–IV colorectal cancer
gan: Guojun Tong, et al.
Cyhoeddwyd: (2024-01-01)

Prognostic markers and molecular pathways in primary colorectal cancer with a high potential of liver metastases: a systems biology approach
gan: Fatemeh Bahramibanan, et al.
Cyhoeddwyd: (2025-01-01)

LncRNA profiles from Notch signaling: Implications for clinical management and tumor microenvironment of colorectal cancer
gan: Qin Dang, et al.
Cyhoeddwyd: (2022-07-01)

The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients
gan: Kelly Offermans, et al.
Cyhoeddwyd: (2024-07-01)

Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor‐associated cardiotoxicity
gan: Lin Liang, et al.
Cyhoeddwyd: (2023-06-01)

Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?
gan: Mahnaz Janghorban, et al.
Cyhoeddwyd: (2018-07-01)

The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma
gan: Bangting Wang, et al.
Cyhoeddwyd: (2024-01-01)

A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients
gan: Xilin Hu, et al.
Cyhoeddwyd: (2023-06-01)

The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy
gan: Abdo Meyiah, et al.
Cyhoeddwyd: (2025-03-01)

Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer
gan: Gen Lin, et al.
Cyhoeddwyd: (2024-02-01)

HAMP as a Prognostic Biomarker for Colorectal Cancer Based on Tumor Microenvironment Analysis
gan: Fang-Ze Wei, et al.
Cyhoeddwyd: (2022-08-01)

Identification of DNA methylation characteristics associated with metastasis and prognosis in colorectal cancer
gan: Fang Qian, et al.
Cyhoeddwyd: (2024-05-01)

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
gan: Qi Wang, et al.
Cyhoeddwyd: (2023-10-01)